Skip to Content

WATSON 3159 (Ursodiol 300 mg)

Pill with imprint WATSON 3159 is White, Capsule-shape and has been identified as Ursodiol 300 mg. It is supplied by Watson Pharmaceuticals.

Ursodiol is used in the treatment of primary biliary cholangitis ; gallbladder disease and belongs to the drug class gallstone solubilizing agents. There is no proven risk in humans during pregnancy. Ursodiol 300 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for WATSON 3159

Ursodiol 300 mg WATSON 3159
Ursodiol 300 mg WATSON 3159 Front
Ursodiol 300 mg WATSON 3159 Back
Ursodiol 300 mg WATSON 3159
Ursodiol 300 mg WATSON 3159

Ursodiol

Imprint
WATSON 3159
Strength
300 mg
Color
White
Size
22.00 mm
Shape
Capsule-shape
Availability
Prescription only
Drug Class
Gallstone solubilizing agents
Pregnancy Category
B - No proven risk in humans
CSA Schedule
Not a controlled drug
Labeler / Supplier
Watson Pharmaceuticals
Inactive Ingredients
silicon dioxide, ferric oxide red, gelatin, magnesium stearate, corn starch, ferrosoferric oxide

Note: Inactive ingredients may vary.

Labelers / Repackagers

NDC Code Labeler / Repackager
00591-3159 Watson Pharmaceuticals, Inc.
68084-0213 Amerisource Health Services

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.